Home Cart 0 Sign in  
X

[ CAS No. 58481-11-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 58481-11-1
Chemical Structure| 58481-11-1
Chemical Structure| 58481-11-1
Structure of 58481-11-1 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 58481-11-1 ]

Related Doc. of [ 58481-11-1 ]

Alternatived Products of [ 58481-11-1 ]

Product Details of [ 58481-11-1 ]

CAS No. :58481-11-1 MDL No. :MFCD01765409
Formula : C7H6ClNO2 Boiling Point : -
Linear Structure Formula :- InChI Key :KKOUHTMLFUAAGG-UHFFFAOYSA-N
M.W : 171.58 Pubchem ID :2736842
Synonyms :

Calculated chemistry of [ 58481-11-1 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.14
Num. rotatable bonds : 2
Num. H-bond acceptors : 3.0
Num. H-bond donors : 0.0
Molar Refractivity : 40.53
TPSA : 39.19 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.33 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.87
Log Po/w (XLOGP3) : 1.43
Log Po/w (WLOGP) : 1.52
Log Po/w (MLOGP) : 0.93
Log Po/w (SILICOS-IT) : 1.83
Consensus Log Po/w : 1.52

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.08
Solubility : 1.44 mg/ml ; 0.00839 mol/l
Class : Soluble
Log S (Ali) : -1.86
Solubility : 2.38 mg/ml ; 0.0139 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.71
Solubility : 0.333 mg/ml ; 0.00194 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.6

Safety of [ 58481-11-1 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 58481-11-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 58481-11-1 ]
  • Downstream synthetic route of [ 58481-11-1 ]

[ 58481-11-1 ] Synthesis Path-Upstream   1~19

  • 1
  • [ 58481-11-1 ]
  • [ 75-05-8 ]
  • [ 6313-54-8 ]
  • [ 1213232-78-0 ]
Reference: [1] Patent: US2007/219186, 2007, A1, . Location in patent: Page/Page column 38
  • 2
  • [ 58481-11-1 ]
  • [ 6937-03-7 ]
Reference: [1] Patent: EP1754706, 2007, A1, . Location in patent: Page/Page column 76-77
  • 3
  • [ 6313-54-8 ]
  • [ 74-88-4 ]
  • [ 58481-11-1 ]
YieldReaction ConditionsOperation in experiment
100%
Stage #1: With sodium hydride In N,N-dimethyl-formamide at 25℃; for 0.5 h; Inert atmosphere
Stage #2: at 50℃; for 2 h;
To a solution of 2-chloroisonicotinic acid (2.0 g, 0.0 12 mole) in DMF (5 mL)under N2 at 25 °C, was added sodium hydride (0.73 g, 0.0 15 mole) and stirred for 0.5hour. Methyl iodide (1.5 mL, 0.025 mole) was added at RT and the reaction mixturewas warmed to 50 °C for 2 hours. The reaction mixture was dissolved in ice water (50mL) and extracted with ethyl acetate (50 mL x 3). Organic layer was washed with brine solution (50 mL) and dried over Na2SO4. The organic phase was concentrated under vacuum to obtain methyl 2-chloroisonicotinate. Yield: 2.1 g (100 percent); Mass (mlz): 172.0 (M+H) , 174.0 (M+H) .
87% With sodium hydrogencarbonate In N,N-dimethyl-formamide at 20℃; for 20 h; Step 1: A mixture of 2-chloro-isonicotinic acid (4.0 g, 25.4 mmol), sodium bicarbonate (5.33 g, 63.48 mmol) and iodomethane (9.7 mL, 156.0 mmol) in N,N dimethyl formamide (60 mL) is stirred at room temperature for 20 hours. The mixture is poured into water and extracted with ether. The organic layer is washed with brine, dried over anhydrous sodium sulfate and filtered. Evaporation of the filtrate provides an oil which solidifies on standing to yield 3.8 g (87percent) of 2-chloro-isonicotinic acid methyl ester as a white solid. MS 172.0 [M+H].
Reference: [1] Patent: WO2017/42643, 2017, A1, . Location in patent: Page/Page column 24; 25
[2] Patent: WO2006/118256, 2006, A1, . Location in patent: Page/Page column 89
[3] Patent: US2007/219186, 2007, A1, . Location in patent: Page/Page column 38
  • 4
  • [ 67-56-1 ]
  • [ 6313-54-8 ]
  • [ 58481-11-1 ]
YieldReaction ConditionsOperation in experiment
91% at 70℃; for 5 h; 2-Chloro-isonicotinic acid (5.10 g, 32.38 mmol) was dissolved in methanol (150 mL). Thionyl chloride (12 mL) was added. This suspension was stirred 5 h at 70 0C and concentrated in vacuo. The residue was dissolved in dichloromethane (250 mL) washed with a solution of 10 percent aqueous K2CO3 (2 x 150 mL) dried with MgSO4, filtered and evaporated. Methyl 2-chloropyridine-4-carboxylate SLA 07150 was obtained as a yellow solid (5.06 g, 91 percent).SLA 07150 MW: 171.58; Yield: 91 percent; Yellow Solid; Mp (0C): 33.0. Rf\\ 0.80 (MeOH:CH2CI2 = 10:90).1H-NMR (CDCI3, δ): 3.98 (s, 3H, CH3), 7.78 (dd, 1 H, J = 5.1 Hz, J = 1.3 Hz, ArH), 7.89 (d, 1 H, J = 0.6 Hz ArH), 8.55 (dd, 1 H, J = 5.1 Hz, J = 0.6 Hz, ArH).
81% at 0 - 20℃; for 16 h; To a solution of 2-chloroisonicotinic acid 19-1 A (5 g, 31.8 mmol) in MeOH (50 mL) was added SOCl2 (2.7 mL, 38.2 mmol) portion-wise at 0 °C, and the mixture was stirred at RT for 16 hr. Solvent was evaporated under reduced pressure. The reaction was quenched with saturated sodium carbonate and diluted with EtOAc (50 mL) washed with water (50 mL), brine (20 mL) and dried over Na2S04, and the organic phase was concentrated under reduced pressure. Obtained crude compound was purified using silica gel chromatography (15percent EtOAc in hexanes) to afford 19- 2A (4.4 g, 25.7 mmol, 81percent yield) as an off-white solid. MS (ESI): m/z 172.1 (M+l)+.
75% for 3 h; Heating / reflux Preparation 1; SYNTHESIS OF 2-[4-(5-FLUORO-2-TRIFLUOROMETHYLBENZOYL)PIPERAZIN-1-YL]ISONICOTINIC ACID METHYL ESTER; A. A mixture of 2-chloroisonicotinic acid (1.000 g, 6.340 mmol) and 5 drops of concentrated sulfuric acid in anhydrous methanol (50 mL) was refluxed for 3 hours. The reaction mixture was concentrated in vacuo, diluted with 20 mL of water and extracted with ethyl acetate. The organic phase was washed with water and brine, dried and concentrated. The compound obtained was used for next step reaction without further purification. Yield 0.816 g, 75percent.
Reference: [1] Patent: WO2008/11478, 2008, A2, . Location in patent: Page/Page column 76
[2] Patent: WO2016/154241, 2016, A1, . Location in patent: Paragraph 578; 579
[3] Patent: US2008/167321, 2008, A1, . Location in patent: Page/Page column 14
[4] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1988, p. 2785 - 2790
[5] Patent: EP1754706, 2007, A1, . Location in patent: Page/Page column 76
[6] Bioorganic and Medicinal Chemistry, 2012, vol. 20, # 11, p. 3615 - 3621
  • 5
  • [ 6313-54-8 ]
  • [ 58481-11-1 ]
YieldReaction ConditionsOperation in experiment
73% With thionyl chloride In methanol; toluene Step 1
Preparation of Methyl-2-chloroisonicotinate
To a solution of thionyl chloride (13.85 mL, 190.38 mmol) in toluene (50 mL) was added 2-chloropyridine-4-carboxylic acid (15 g, 95 mmol).
The solution was heated to reflux for 3 hours.
The resulting brown color solution was cooled to room temperature, and methanol (11.56 mL, 285.6 mmol) was added slowly dropwise.
The mixture was brought to reflux for 15 minutes and became clear.
The solution was then cooled to room temperature and poured into water (150 mL), basified with 50 percent sodium hydroxide and extracted with ethyl acetate (2*200 ml).
The organic layer was separated and washed with brine, dried with magnesium sulfate, filtered and concentrated to yield the titled compound (11.93 g, 73percent) as a brown color solid.
This was used in the next step without further purification.
83% With thionyl chloride In methanol; water; toluene Step 2
Preparation of Methyl 2-Chloroisonicotinate:
To a solution of thionyl chloride (15.0 g, 0.127 mol) in 20 mL of toluene was added 2-chloroisonicotinic acid (10.0 g, 0.063 mol) and the reaction was heated at reflux until gas evolution ceased.
Then a solution of methanol (7.7 mL, 0.19 mol) in 10 mL of toluene was added at room temperature over 15 min.
The reaction mixture was then refluxed for 1 h and then cooled to room temperature.
The clear solution was poured into 100 mL of water, basified with 40percent NaOH and extracted with ethyl acetate.
The organic layer was washed with brine, dried over magnesium sulfate filtered.
The filtrate was concentrated in vacuo to give 8.2 g (83percent) of product as a brown oil which solidified upon standing, mp: 36-37 C.
Reference: [1] Patent: US6509361, 2003, B1,
[2] Helvetica Chimica Acta, 1951, vol. 34, p. 496,499
[3] Patent: US6509361, 2003, B1,
[4] Patent: US6316464, 2001, B1,
  • 6
  • [ 67-56-1 ]
  • [ 65287-34-5 ]
  • [ 58481-11-1 ]
Reference: [1] Patent: US2006/205728, 2006, A1, . Location in patent: Page/Page column 31
  • 7
  • [ 67-56-1 ]
  • [ 58481-11-1 ]
Reference: [1] Patent: WO2006/35967, 2006, A1, . Location in patent: Page/Page column 92-93
  • 8
  • [ 3783-38-8 ]
  • [ 58481-11-1 ]
Reference: [1] Journal of Organic Chemistry, 1997, vol. 62, # 10, p. 3158 - 3175
  • 9
  • [ 6313-54-8 ]
  • [ 34472-65-6 ]
  • [ 58481-11-1 ]
Reference: [1] Patent: WO2009/32667, 2009, A1, . Location in patent: Page/Page column 187
  • 10
  • [ 58481-11-1 ]
  • [ 26156-51-4 ]
YieldReaction ConditionsOperation in experiment
75% With sodium methylate In 1,4-dioxane; water Step 1
Preparation of Methyl 2-Methoxyisonicotinate
A mixture of methyl 2-chloroisonicotinate (5.23 g, 0.030 mol) and sodium methoxide (2.47 g, 0.045 mol) in 15 mL of dioxane was heated at reflux for 1.5 hours.
After the reaction mixture was cooled, water was added and the resulting mixture was extracted with methylene chloride.
The organic layer was washed with brine, dried over magnesium sulfate and filtered.
The filtrate was concentrated in vacuo to give 3.76 g (75percent) of product as a yellow oil: Anal. Calc'd. for C8H9NO3: C, 57.48; H, 5.43; N, 8.38. Found: C, 57.07; H, 5.54; N, 8.34.
Reference: [1] Patent: US6509361, 2003, B1,
  • 11
  • [ 58481-11-1 ]
  • [ 124-41-4 ]
  • [ 26156-51-4 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1988, p. 2785 - 2790
[2] Yakugaku Zasshi, 1952, vol. 72, p. 1639,1641[3] Chem.Abstr., 1953, p. 9325
[4] Bioorganic and Medicinal Chemistry, 2012, vol. 20, # 17, p. 5235 - 5246
  • 12
  • [ 58481-11-1 ]
  • [ 100704-10-7 ]
YieldReaction ConditionsOperation in experiment
95%
Stage #1: With diisobutylaluminium hydride In tetrahydrofuran; hexane at 0℃; for 2 h;
Stage #2: With hydrogenchloride In tetrahydrofuran; hexane; water at 20℃; for 1 h;
Stage #3: With sodium hydrogencarbonate In tetrahydrofuran; hexane; water
Reference Example 7
2-Chloropyridine-4-methanol (Reference compound No.7-1)
A 0.95 M solution of diisobutylaluminum hydride in hexane (200 mL, 190 mmol) was added dropwise to a solution of 2-chloroisonicotinic acid methyl ester (11 g, 62 mmol) in anhydrous tetrahydrofuran (300 mL) under a nitrogen atmosphere under ice-cooling, and then the mixture was stirred under ice-cooling for 2 hours.
After that, 1 N hydrochloric acid (200 mL) was added thereto, the mixture was stirred at room temperature for 1 hour.
A saturated aqueous sodium hydrogencarbonate solution (400 mL) was added to the reaction mixture, then the whole was extracted with ethyl acetate (100 mL) three times.
The ethyl acetate layer was dried over anhydrous magnesium sulfate, and then the solvent was evaporated under reduced pressure to give 8.5 g of the title reference compound as a white solid. (Yield 95percent)
1H-NMR(500MHz,DMSO-d6)
δ 4.56(d,J = 5.8 Hz,2H),5.54(t,J = 5.8 Hz,1H),7.34(d,J = 4.9 Hz,1H),7.41(s,1H),8.34(d,J = 4.9 Hz,1H)
94%
Stage #1: With diisobutylaluminium hydride In tetrahydrofuran; hexanes at -78 - 20℃; for 4.5 h;
Stage #2: With ammonium chloride In tetrahydrofuran; hexanes; water
Methyl 2-chloropyridine-4-carboxylate (2.50 g, 14.60 mmol) was dissolved in anhydrous THF (50 mL) and this solution was cooled to -78 0C under N2 atmosphere. Diisobutylaluminium hydride 1.0 M in hexanes (63.3 mL, 63.30 mmol) was added dropwise stabilizing the temperature between - <n="79"/>50 0C and -70 0C. The reaction mixture was stirred 1 .5 h at -78 0C and allowed to stand at room temperature for 3 h. A solution of aqueous 10 percent NH4CI was slowly added and the mixture was extracted with ethyl acetate (3 x 300 ml_). The combined organic layers were washed with water (3 x 20 ml_), brine (2 x 20 ml_), dried over MgSO4, filtered and evaporated. (2- Chloropyridin-4-yl)methanol SLA 07152 was obtained as a yellow oil (1 .97 g, 94 percent yield).SLA 07152MW: 143.71 ; Yield: 94 percent; Yellow Oil. Rf : 0.35 (EtOAc:cyclohexane = 30:70).1H-NMR (CDCI3, δ): 2.95 (s broad, 1 H, OH), 4.75 (s, 2H, CH2O), 7.21 (dd, 1 H, J = 5.1 Hz, J = 1.2 Hz, ArH), 7.37 (d, 1 H, J = 1.2 Hz ArH), 8.29 (d, 1 H, J = 5.1 Hz, ArH).MS-ESI m/z (rel. int.): 144.0 ([MH]+, 100).HP LC: Method A, detection UV 254 nm, SLA 07152 RT = 3.45 min, peak area 99.9 percent.
71% With lithium borohydride In tetrahydrofuran at 25 - 30℃; for 3 h; Inert atmosphere; Cooling To a cooled solution of methyl 2-chloroisonicotinate (1.7 g, 0.009 mole) inTHF (30 mL) under N2, was added lithium borohydride (0.43 g, 0.019 mole) inportions. The reaction mixture was warmed to RT and stirred further for 3 hours. Thereaction mixture was concentrated under reduced pressure; residue was dissolved inice cold water (50 mL) and extracted with ethyl acetate (50 mL x 3). Organic layer was washed with brine solution (50 mL) and dried over Na2SO4. The organic phase was concentrated under vacuum to obtain the crude compound which was further purified by flash chromatography using ethyl acetate: n-hexane (40: 60) to afford (2-chloropyridin-4-yl)-methanol.Yield: 1.0 g (71 percent); ‘H - NMR (CDC13, 400MHz) ö ppm: 2.29 (bs, 1H), 4.75 (s, 2H),7.20 - 7.21 (d, J = 4.9 Hz, 1H), 7.31 (s, 1H), 8.32 - 8.33 (d, J = 5.0 Hz, 1H); Mass(m/z): 144.0 (M+H), 145.9 (M+H).
70.8%
Stage #1: With lithium borohydride In tetrahydrofuran; methanol at 0 - 20℃; for 4 h;
Stage #2: With hydrogenchloride In tetrahydrofuran; methanol; water at 0℃;
A sample of methyl 2-chloroisonicotinate (5.00 g, 29.14 mmol) was dissolved in 10 niL THF, treated with 10 drops of methanol, and cooled to 0 0C. The solution was treated with lithium borohydride solution (21.86 mL of 1 M in THF, 43.71mmol) and then allowed to warm to room temp. After 4 h the solution was cooled to 0 0C and quenched with 1 N HCl solution. The pH was adjusted to pH 10 with 1 N NaOH solution, and the reaction mixture was extracted with EtOAc. The organic extracts were washed with brine and concentrated in vacuo yielding 2.96 g (70.8percent) of product.1H NMR (300 MHz, CD3CN) δ 8.32 (d, 1 H), 7.39 (s, 1 H), 7.29 (d, 1 H), 4.62 (s, 2 H) and 3.53 ppm (bs, 1 H).
70.8%
Stage #1: With methanol; lithium borohydride In tetrahydrofuran at 0 - 20℃; for 4 h;
Stage #2: With hydrogenchloride; water In tetrahydrofuran; methanol at 0℃;
Intermediate T : Preparation of 2-chloro-4-(chloromethyl)pyridine; Step 1: Preparation of (2-chloropyridin-4-yl)methanol; A sample of methyl 2-chloroisonicotinate (5.00 g, 29.14 mmol) was dissolved in 10 mL THF, treated with 10 drops of methanol, and cooled to 0 °C. The solution was treated with lithium borohydride solution (21.86 mL of 1 M in THF, 43.71mmol) and then allowed to warm to room temp. After 4 h the solution was cooled to 0 °C and quenched with 1 N HC1 solution. The pH was adjusted to pH 10 with 1 N NaOH solution, and the reaction mixture was extracted with EtOAc. The organic extracts were washed with brine and concentrated in vacuo yielding 2.96 g (70.8percent) of product.'H NMR (300 MHz, CD3CN) 5 8.32 (d, 1 H), 7.39 (s, 1 H), 7.29 (d, 1 H), 4.62 (s, 2 H) and 3.53 ppm (bs, 1 H).
70.8% With lithium borohydride In tetrahydrofuran; methanol at 20℃; for 4 h; Preparation of (2-chloropyridin-4-yl)methanolA sample of methyl 2-chloroisonicotinate (5.00 g, 29.14 mmol) was dissolved in 10 mL THF, treated with 10 drops of methanol, and cooled to 0 C. The solution was treated with lithium borohydride solution (21.86 mL of 1 M in THF, 43.71 mmol) and then allowed to warm to room temp. After 4 h the solution was cooled to 0 C and quenched with 1 N HCl solution. The pH was adjusted to pH 10 with 1 N NaOH solution, and the reaction mixture was extracted with EtOAc. The organic extracts were washed with brine and concentrated in vacuo yielding 2.96 g (70.8percent) of product.1H NMR (300 MHz, CD3CN) ? 8.32 (d, 1 H), 7.39 (s, 1 H), 7.29 (d, 1 H), 4.62 (s, 2 H) and 3.53 ppm (bs, 1 H).

Reference: [1] Patent: EP1602647, 2005, A1, . Location in patent: Page/Page column 48
[2] Patent: WO2008/11478, 2008, A2, . Location in patent: Page/Page column 76-77
[3] Patent: WO2017/42643, 2017, A1, . Location in patent: Page/Page column 25
[4] Patent: WO2006/96338, 2006, A1, . Location in patent: Page/Page column 47
[5] Patent: WO2006/2383, 2006, A2, . Location in patent: Page/Page column 55
[6] Patent: WO2006/133006, 2006, A2, . Location in patent: Page/Page column 51-52
[7] Patent: WO2006/35967, 2006, A1, . Location in patent: Page/Page column 93
[8] Bioorganic and Medicinal Chemistry Letters, 2011, vol. 21, # 8, p. 2224 - 2228
  • 13
  • [ 58481-11-1 ]
  • [ 100704-10-7 ]
  • [ 101066-61-9 ]
Reference: [1] Heterocycles, 1998, vol. 48, # 10, p. 2149 - 2155
  • 14
  • [ 58481-11-1 ]
  • [ 64-17-5 ]
  • [ 100704-10-7 ]
  • [ 118287-89-1 ]
Reference: [1] Heterocycles, 1998, vol. 48, # 10, p. 2149 - 2155
  • 15
  • [ 58481-11-1 ]
  • [ 83004-15-3 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2011, vol. 21, # 8, p. 2224 - 2228
  • 16
  • [ 58481-11-1 ]
  • [ 123148-66-3 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2012, vol. 20, # 17, p. 5235 - 5246
  • 17
  • [ 58481-11-1 ]
  • [ 101066-61-9 ]
Reference: [1] Patent: US4800206, 1989, A,
  • 18
  • [ 58481-11-1 ]
  • [ 100704-10-7 ]
  • [ 101066-61-9 ]
Reference: [1] Heterocycles, 1998, vol. 48, # 10, p. 2149 - 2155
  • 19
  • [ 58481-11-1 ]
  • [ 101066-61-9 ]
Reference: [1] Patent: WO2008/11478, 2008, A2,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 58481-11-1 ]

Chlorides

Chemical Structure| 3998-88-7

[ 3998-88-7 ]

Ethyl 2-chloro-6-methylisonicotinate

Similarity: 0.91

Chemical Structure| 787596-41-2

[ 787596-41-2 ]

Methyl 2-chloro-3-methylisonicotinate

Similarity: 0.91

Chemical Structure| 1073182-59-8

[ 1073182-59-8 ]

Methyl 5-amino-2-chloroisonicotinate

Similarity: 0.91

Chemical Structure| 42521-09-5

[ 42521-09-5 ]

Methyl 2,6-dichloroisonicotinate

Similarity: 0.89

Chemical Structure| 623585-74-0

[ 623585-74-0 ]

Methyl 2,5-dichloroisonicotinate

Similarity: 0.88

Esters

Chemical Structure| 3998-88-7

[ 3998-88-7 ]

Ethyl 2-chloro-6-methylisonicotinate

Similarity: 0.91

Chemical Structure| 787596-41-2

[ 787596-41-2 ]

Methyl 2-chloro-3-methylisonicotinate

Similarity: 0.91

Chemical Structure| 1073182-59-8

[ 1073182-59-8 ]

Methyl 5-amino-2-chloroisonicotinate

Similarity: 0.91

Chemical Structure| 42521-09-5

[ 42521-09-5 ]

Methyl 2,6-dichloroisonicotinate

Similarity: 0.89

Chemical Structure| 623585-74-0

[ 623585-74-0 ]

Methyl 2,5-dichloroisonicotinate

Similarity: 0.88

Related Parent Nucleus of
[ 58481-11-1 ]

Pyridines

Chemical Structure| 3998-88-7

[ 3998-88-7 ]

Ethyl 2-chloro-6-methylisonicotinate

Similarity: 0.91

Chemical Structure| 787596-41-2

[ 787596-41-2 ]

Methyl 2-chloro-3-methylisonicotinate

Similarity: 0.91

Chemical Structure| 1073182-59-8

[ 1073182-59-8 ]

Methyl 5-amino-2-chloroisonicotinate

Similarity: 0.91

Chemical Structure| 42521-09-5

[ 42521-09-5 ]

Methyl 2,6-dichloroisonicotinate

Similarity: 0.89

Chemical Structure| 623585-74-0

[ 623585-74-0 ]

Methyl 2,5-dichloroisonicotinate

Similarity: 0.88